Last reviewed · How we verify
NCT06948773: HELIX
A Study of the Helix Surgical System in Primary Open-Angle Glaucoma (POAG) and Cataract (HELIX)
NA trial testing Helix Surgical System in Primary Open Angle Glaucoma in 25 participants. Currently enrolling.
30 September 2026
Quick facts
| Lead sponsor | Sight Sciences, Inc. |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 25 |
| Start date | 21 May 2025 |
| Primary completion | 30 September 2026 |
| Estimated completion | 30 September 2026 |
| Sites | 1 location across Panama |
Drugs / interventions tested
- Helix Surgical System
Conditions studied
- Primary Open Angle Glaucoma — all drugs for Primary Open Angle Glaucoma →
- Cataract — all drugs for Cataract →
Sponsor
Sight Sciences, Inc. — full company profile →
Who can join
45 and older, any sex, with Primary Open Angle Glaucoma or Cataract. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A study to assess the safety of the Helix Surgical System in cataract surgery and to gain early evidence of its effectiveness in lowering intraocular pressure (IOP) in subjects with mild to moderate primary open-angle glaucoma (POAG) and cataracts.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06948773
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Primary Open Angle Glaucoma
Currently open trials in the same condition.
- NCT07390890 — DSLT for Reducing Medication in Glaucoma · recruiting
- NCT07447011 — Glaucoma Respsosne to Lifestyle Corrections in Sleep Apnea · NA · recruiting
- NCT07358650 — Clinical Study Evaluating the Safety and Performance of the MIST Device for Intraocular Pressure Reduction in Patients W · NA · recruiting
- NCT05439161 — XEN Glaucoma Gel Stent Versus Trabeculectomy · NA · recruiting
- NCT05844384 — Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial · NA · recruiting
Other Sight Sciences, Inc. trials
Trials by the same sponsor.
- NCT06407973 — A Clinical Trial Comparing the OMNI Surgical System to Standard Medical Treatment in Patients With Primary Open Angle Gl · Phase 4 · terminated
- NCT04658095 — Study of OMNI Surgical System and iStent for Eyes With OAG (Trident) · NA · terminated
- NCT05044793 — A Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System · completed
- NCT04872348 — An Observational Multicenter Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System In Pseud · completed
- NCT04795752 — Safety And Effectiveness Of The TearCare® System In The Treatment Of The Signs And Symptoms Of Dry Eye Disease (SAHARA) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06948773 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sight Sciences, Inc.
- Last refreshed: 16 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06948773.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing